UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended September 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-14053 Milestone Scientific Inc. (Exact name of registrant as specified in its charter) Delaware 13-3545623 State or other jurisdiction o ...

Milestone Scientific Inc. (NYSE:MLSS) Q2 2021 Earnings Conference Call August 16, 2021 11:00 AM ET Company Participants Natalya Rudman - Investor Relations Arjan Haverhals - Chief Executive Officer Keisha Harcum - Controller Conference Call Participants Anthony Vendetti - Maxim Group James Terwilliger - Northland Capital Markets Operator Good day, ladies and gentlemen, and welcome to the Milestone Scientific Second Quarter 2021 Business Update Call [Operator Instructions]. At this time, it is my pleasure t ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-14053 Milestone Scientific Inc. (Exact name of registrant as specified in its charter) Delaware 13-3545623 State or other jurisdiction of Inc ...

Milestone Scientific Inc. (NYSE:MLSS) Q1 2021 Earnings Conference Call May 17, 2021 11:00 AM ET Company Participants David Waldman - IR Len Osser - Interim Chief Executive Officer Arjan Haverhals - President of Milestone Scientific and CEO of Wand Dental Inc. Keisha Harcum - Controller Conference Call Participants Anthony Vendetti - Maxim Group Operator Greetings, and welcome to the Milestone Scientific First Quarter Conference Call. At this time, all participants are in a listen-only mode. A question-and-a ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-14053 Milestone Scientific Inc. (Exact name of registrant as specified in its charter) State or other jurisdiction of Incorporation or organ ...

Milestone Scientific, Inc. (NYSE:MLSS) Q4 2020 Earnings Conference Call April 1, 2021 4:30 PM ET Company Participants Natalya Rudman ??? Senior Vice President and Director of Market Intelligence, Crescendo Communications, LLC Leonard Osser ??? Interim Chief Executive Officer Arjan Haverhals ??? President-Milestone Scientific and Chief Executive Officer-Wand Dental Joseph D???Agostino ??? Chief Financial Officer Conference Call Participants Anthony Vendetti ??? Maxim Gary Carol ??? Private Investor Derek Row ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020. Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-14053 Milestone Scientific Inc. (Exact name of registrant as specified in its charter) Delaware 13-3545623 State or other jurisdicti ...

Milestone Scientific, Inc. (NYSE:MLSS) Q3 2020 Earnings Conference Call November 17, 2020 8:30 AM ET Company Participants David Waldman - IR, Crescendo Communications, LLC Leonard Osser - Interim Chief Executive Officer & Director of China Operations Arjan Haverhals - President & Chief Executive Officer of Wand Dental Inc. Joseph D'Agostino - Chief Financial Officer Conference Call Participants Anthony Vendetti - Maxim Group James Terwilliger - Northland Capital Markets Operator Greetings, and welcome to Mi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended September 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-14053 Milestone Scientific Inc. (Exact name of registrant as specified in its charter) Delaware 13-3545623 State or other jurisdiction o ...

Milestone Scientific, Inc. (NYSE:MLSS) Q2 2020 Earnings Conference Call August 17, 2020 8:30 AM ET Company Participants David Waldman - IR, Crescendo Communications, LLC Leonard Osser - Interim Chief Executive Officer & Director of China Operations Arjan Haverhals - Chief Executive Officer of Wand Dental Inc. Joseph D'Agostino - Chief Financial Officer Conference Call Participants Anthony Vendetti - Maxim Group James Dowling - Jefferies Capital Operator Greetings. Welcome to the Milestone Scientific Second ...